{"nct_id":"NCT03451422","title":"Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus","status":"COMPLETED","status_verified_date":"2022-08","start_date":"2018-04-10","start_date_type":"ACTUAL","primary_completion_date":"2021-10-12","primary_completion_date_type":"ACTUAL","completion_date":"2021-10-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}